Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes

Archives of Physiology and Biochemistry

Volumn 119, Issue 2, 2013, Pages 52-64

  Fleuren, Wilco W M ^a,b   Linssen, Margot M L ^c   Toonen, Erik J M ^a   Van Der Zon, Gerard C M ^c   Guigas, Bruno ^c   De Vlieg, Jacob ^a,d   Dokter, Wim H A ^e   Ouwens, D Margriet ^f,g   Alkema, Wynand ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS BIOINFORMATICS CENTRE   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NETHERLANDS ESCIENCE CENTER   (Netherlands)

^e SYNTHON BV   (Netherlands)

^f LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Gene profiling; Glucocorticoids; Metabolic dysfunction

Indexed keywords

ADIPOCYTOKINE; DEOXYGLUCOSE; GLUCOCORTICOID; INSULIN; PREDNISOLONE; TRANSCRIPTOME;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN 3T3; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNITY; INSULIN RESISTANCE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; WNT SIGNALING PATHWAY;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; DEOXYGLUCOSE; GENE EXPRESSION; GLUCOCORTICOIDS; IMMUNITY; INSULIN; INSULIN RESISTANCE; MICE; PREDNISOLONE; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TRANSCRIPTOME; WNT SIGNALING PATHWAY;

EID: 84877109088     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2013.774022     Document Type: Article

References (84)

1. Abiola M, Favier M, Christodoulou-Vafeiadou E, et al. (2009). Activation of Wnt/beta-catenin signalling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One, 4:e8509-8522.
2. Alessi MC, Bastelica D, Morange P, et al. (2000). Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes, 49:1374-80.
3. Anagnostou SH, Shepherd PR. (2008). Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines. Biochem J, 416:211-18.
4. Bala M, Kopp A, Wurm S, et al. (2011). Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes. Exp Clin Endocrinol Diabetes, 119:370-6.
5. Bastard JP, Maachi M, Lagathu C, et al. (2006). Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw, 17:4-12.
6. Bazuine M, Carlotti F, Tafrechi RS, et al. (2004). Mitogen-activated protein kinase (MAPK) phosphatase-1 and-4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipo-cytes. Mol Endocrinol, 18:1697-707.
7. Bennett CN, Ross SE, Longo KA, et al. (2002). Regulation of Wnt signalling during adipogenesis. J Biol Chem, 277:30998-1004.
8. Buren J, Lai YC, Lungren M, et al. (2008). Insulin action and signalling in fat and muscle from dexamethasone-treated rats. Arch Biochem Biophys, 474:91-101.
9. Buren J, Liu HX, Jensen J, Eriksson JW. (2002). Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur J Endocrinol, 146:419-29.
10. Chan SS, Twigg SM, Firth SM, Baxter RC. (2005). Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J Clin Endocrinol Metab, 90:6588-95.
11. Chavey C, Lazennec G, Lagarrigue S, et al. (2009). CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab, 9:339-49.
12. Chen H, Gu X, Liu Y, et al. (2011). PDGF signalling controls age-dependent proliferation in pancreatic beta-cells. Nature, 478: 349-55.
13. Christodoulides C, Laudes M, Cawthorn WP, et al. (2006). The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci, 119:2613-20.
14. Chrousos GP, Kino T. (2009). Glucocorticoid signalling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann NY Acad Sci, 1179:153-66.
15. Clemmons DR. (2004). Role of insulin-like growth factor in maintaining normal glucose homeostasis. Horm Res, 62 Suppl 1:77-82.
16. Dahlman I, Elsen M, Tennagels N, et al. (2012). Functional annotation of the human fat cell secretome. Arch Physiol Biochem, 118:84-91.
17. De Bosscher K, Haegeman G. (2009). Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol, 23: 281-91.
18. De Roos B, Rungapamestry V, Ross K, et al. (2009). Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics, 9:3244-56.
19. Del Rosso Do JQ. (2006). Combination topical therapy for the treatment of psoriasis. J Drugs Dermatol, 5:232-4.
20. Fasshauer M, Paschke R. (2003). Regulation of adipocytokines and insulin resistance. Diabetologia, 46:1594-603.
21. Fleuren WW, Verhoeven S, Frijters R, et al. (2011). CoPub update: CoPub 5.0 a text mining system to answer biological questions. Nucleic Acids Res, 39:W450-4.
22. Frijters R, Fleuren W, Toonen EJ, et al. (2010). Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC Genomics, 11: 359.
23. Fujimoto S, Mochizuki K, Shimada M, et alet al. (2010). Insulin resistance induced by a high-fat diet is associated with the induction of genes related to leukocyte activation in rat peripheral leukocytes. Life Sci, 87:679-85.
24. Garcia-Diaz D F, Arellano AV, Milagro FI, et al. (2011). Glucose and insulin modify thrombospondin 1 expression and secretion in primary adipocytes from diet-induced obese rats. J Physiol Biochem, 67: 453-61.
25. Gronning LM, Tingsabadh R, Hardy K, et al. (2006). Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway. Am J Physiol Endocrinol Metab, 290:E599-606.
26. Guo X, Wang XF. (2009). Signalling cross-talk between TGF-beta/BMP and other pathways. Cell Res, 19:71-88.
27. Harford KA, Reynolds CM, McGillicuddy FC, Roche HM. (2011). Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc, 70, 1-10.
28. Heilbronn LK, Campbell LV. (2008). Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des, 14:1225-30.
29. Hillier SG. (2007). Diamonds are forever: the cortisone legacy. J Endocrinol, 195:1-6.
30. Hoehn KL, Hohnen-Behrens C, Cederberg A, et al. (2008). IRS1-independent defects define major nodes of insulin resistance. Cell Metab, 7:421-33.
31. Hu W, Li L, Yang M, et al. (2012). Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J Clin Endocrinol Metab, 98:290-298.
32. Huang Da W, Sherman BT, Lempicki RA. (2009a). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 37:1-13.
33. Huang Da W, Sherman BT, Lempicki RA. (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4:44-57.
34. Ikubo M, Wada T, Fukui K, et al. (2009). Impact of lipid phosphatases SHIP2 and PTEN on the time-and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab, 296:E157-64.
35. Jin T. (2008). The WNT signalling pathway and diabetes mellitus. Diabetologia, 51:1771-80.
36. Kamei N, Tobe K, Suzuki R, et al. (2006). Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem, 281:26602-14.
37. Kershaw EE, Flier JS. (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab, 89:2548-56.
38. Kim HS, Ali O, Shim M, et al. (2007). Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo. Pediatr Res, 61:159-64.
39. Kino T. (2007). Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids. Horm Metab Res, 39:420-24.
40. Lagathu C, Bastard JP, Auclair M, et al. (2003). Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun, 311:372-9.
41. Lazar DF, Saltiel AR. (2006). Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat Rev Drug Discov, 5:333-42.
42. Lehr S, Hartwig S, Lamers D, et al. (2011). Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics, doi: 0.1074/mcp.M111.010504:1-13.
43. Lehr S, Hartwig S, Lamers D, et al. (2012). Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics, 11:M111 010504:-1-13.
44. Lin HM, Lee JH, Yadav H, et al. (2009). Transforming growth factor-beta/Smad3 signalling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem, 284:12246-57.
45. Linssen MM, van Raalte DH, Toonen EJ, et al. (2011). Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells. Cell Signal, 23:1708-15.
46. Liu Z, Habener JF. (2010). Wnt signalling in pancreatic islets. Adv Exp Med Biol, 654:391-419.
47. Longo KA, Kennell JA, Ochocinska MJ, et al. (2002). Wnt signalling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem, 277:38239-44.
48. Lu NZ, Cidlowski JA. (2006). Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol, 16:301-7.
49. McGillicuddy FC, Harford KA, Reynolds CM, et al. (2011). Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes, 60:1688-98.
50. Mehta NN, McGillicuddy FC, Anderson PD, et al. (2010). Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes, 59:172-81.
51. Mori H, Prestwich TC, Reid MA, et al. (2012). Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest, 122:2405-16.
52. Murdolo G, Herder C, Wang Z, et al. (2008). In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals. Am J Physiol Endocrinol Metab, 295:E1095-105.
53. Nakashima N, Sharma PM, Imamura T, et al. (2000). The tumor suppressor PTEN negatively regulates insulin signalling in 3T3-L1 adipocytes. J Biol Chem, 275:12889-95.
54. Oh DY, Olefsky JM. (2010). Medicine. Wnt fans the flames in obesity. Science, 329:397-8.
55. Ouchi N, Higuchi A, Ohashi K, et al. (2010). Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science, 329:454-7.
56. Ouchi N, Parker JL, Lugus JJ, Walsh K. (2011). Adipokines in inflammation and metabolic disease. Nat Rev Immunol, 11:85-97.
57. Rhen T, Cidlowski JA. (2005). Antiinflammatory action of glucocortic-oids-new mechanisms for old drugs. N Engl J Med, 353:1711-23.
58. Rockall AG, Sohaib SA, Evans D, et al. (2003). Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome. Eur J Endocrinol, 149:561-7.
59. Ross SE, Hemati N, Longo KA, et al. (2000). Inhibition of adipogenesis by Wnt signalling. Science, 289:950-53.
60. Rotter V, Nagaev I, Smith U. (2003). Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem, 278:45777-84.
61. Sakoda H, Ogihara T, Anai M, et al. (2000). Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes, 49:1700-8.
62. Schacke H, Docke WD, Asadullah K. (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther, 96:23-43.
63. Schacke H, Rehwinkel H, Asadullah K, Cato AC. (2006). Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Exp Dermatol, 15:565-73.
64. Schinner S. (2009). Wnt-signalling and the metabolic syndrome. Horm Metab Res, 41:159-63.
65. Schwartz M, Cohen R. (2008). Optimizing conventional therapy for inflammatory bowel disease. Curr Gastroenterol Rep, 10:585-90.
66. Sell H, Eckel J. (2007). Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol, 18:258-62.
67. Tan CK, Leuenberger N, Tan MJ, et al. (2011). Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet. Diabetes, 60:464-76.
68. Tang X, Powelka AM, Soriano NA, et al. (2005). PTEN, but not SHIP2, suppresses insulin signalling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J Biol Chem, 280:22523-9.
69. Taskinen MR, Nikkila EA, Pelkonen R, Sane T. (1983). Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab, 57:619-26.
70. Tateya S, Tamori Y, Kawaguchi T, et al. (2010). An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology, 151:971-9.
71. The R Project for Statistical Computing package. Available from: http://www.r-project.org
72. Toonen EJ, Fleuren WW, Nassander U, et al. (2011). Prednisolone-induced changes in gene-expression profiles in healthy volunteers. Pharmacogenomics, 12:985-98.
73. Tsurutani Y, Fujimoto M, Takemoto M, et al. (2011). The roles of transforming growth factor-beta and Smad3 signalling in adipocyte differentiation and obesity. Biochem Biophys Res Commun, 407: 68-73.
74. Van den Berghe N, Ouwens DM, Maassen JA, et al. (1994). Activation of the Ras/mitogen-activated protein kinase signalling pathway alone is not sufficient to induce glucose uptake in 3T3-L1 adipocytes. Mol Cell Biol, 14:2372-7.
75. Van Raalte, D. H., Ouwens, D. M. & Diamant, M. (2009). Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest, 39:81-93.
76. Wajchenberg BL. (2000). Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev, 21:697-738.
77. Walia B, Wang L, Merlin D, Sitaraman SV. (2003). TGF-beta down-regulates IL-6 signalling in intestinal epithelial cells: critical role of SMAD-2. FASEB J, 17:2130-2.
78. Whiteman EL, Chen JJ, Birnbaum MJ. (2003). Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates. Endocrinology, 144:3811-20.
79. Yadav H, Quijano C, Kamaraju AK, et al. (2011). Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signalling. Cell Metab, 14:67-79.
80. Yamamoto T, Matsuda T, Muraguchi A, et al. (2001). Cross-talk between IL-6 and TGF-beta signalling in hepatoma cells. FEBS Lett, 492: 247-53.
81. Yang H, Mammen J, Wei W, et al. (2005). Expression and activity of C/EBPbeta and delta are upregulated by dexamethasone in skeletal muscle. J Cell Physiol, 204:219-26.
82. Yu X, Shen N, Zhang ML, et al. (2011). Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice. EMBO J, 30:3754-65.
83. Yuasa T, Kakuhata R, Kishi K, et al. (2004). Platelet-derived growth factor stimulates glucose transport in skeletal muscles of transgenic mice specifically expressing platelet-derived growth factor receptor in the muscle, but it does not affect blood glucose levels. Diabetes, 53: 2776-86.
84. Zhang J, He XC, Tong WG, et al. (2006). Bone morphogenetic protein signalling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion. Stem Cells, 24:2826-39.